Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cellbxhealth Plc ADR
(OP:
ANPCY
)
0.0670
UNCHANGED
Last Price
Updated: 2:45 PM EST, Dec 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cellbxhealth Plc ADR
< Previous
1
2
3
4
5
6
Next >
Angle PLC Announces Streamlining of Operations to Increase Cash Runway
October 18, 2022
Via
ACCESSWIRE
Angle PLC announces TR-1: Notification of major holdings
October 17, 2022
Via
ACCESSWIRE
Angle PLC Announces First Regional Distribution Agreement
October 12, 2022
Via
ACCESSWIRE
Angle PLC Announces Holding(s) in Company
September 30, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
September 30, 2022
Via
ACCESSWIRE
Angle PLC Announces Interim Results
September 29, 2022
Via
ACCESSWIRE
Angle PLC Announces Positive Headline Results From Ovarian Study
September 29, 2022
Via
ACCESSWIRE
Angle PLC announces Study using Parsortix in head and neck cancer
September 28, 2022
Via
ACCESSWIRE
Angle PLC Announces New Poster Presented at ASCP Meeting
September 13, 2022
Via
ACCESSWIRE
Angle PLC Announces Novel Assay; Predicts Malignancy in Pelvic Mass
September 12, 2022
Via
ACCESSWIRE
Angle PLC Announces Notice of Interim Results and Webcast
September 01, 2022
Via
ACCESSWIRE
Angle PLC Announces Issue of Equity
July 08, 2022
Exercise of Options and Total Voting Rights
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Result of 2022 Annual General Meeting
June 29, 2022
GUILDFORD, SURREY / ACCESSWIRE / June 29, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today,...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep
June 27, 2022
BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Issue of Equity
June 23, 2022
Exercise of Options and Total Voting Rights
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Secured Contract From Pharma Services Customer
June 22, 2022
Additional contract for a new clinical trial
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Predicting Immunotherapy Response in SCLC
June 16, 2022
PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCER
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Potential Role of Invasive Cellular Protrusions
June 14, 2022
Prostate cancer cells may use invasive cellular protrusions to aid entry into the blood stream, a potential target in the metastatic process for novel therapy development
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Partnership with Major United States Urology Group
May 30, 2022
PARTNERSHIP ESTABLISHED WITH A MAJOR UNITED STATES UROLOGY GROUP TO CONDUCT CLINICAL STUDIES IN PROSTATE CANCER AND AS A POTENTIAL ROUTE TO MARKET
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Molecular Characterisation of CTCs
May 27, 2022
Parsortix system harvests intact CTCs for single-cell whole genomic sequencing from frozen and fresh blood samples with the same efficiency
From
ANGLE plc
Via
AccessWire
ANGLE receives FDA clearance for Parsortix
May 25, 2022
ANGLE ACHIEVES WORLD FIRST WITH FDA CLEARANCE FOR ITS PARSORTIX SYSTEMFDA De Novo product clearance to harvest cancer cells from blood for subsequent analysis offers the prospect of a new era of...
From
ANGLE plc
Via
AccessWire
Angle PLC - Prostate Cancer UK Funds New Study Using Parsortix
May 20, 2022
Research Into the Use of Parsortix-Based CTC Blood Test To Assess Whether Prostate Cancer Patients Require Prostatectomy SurgeryPotential for a New Standard of Care in an Area of High Unmet Medical...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Preliminary Results
April 28, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Notice of Preliminary Results and Webcast
April 20, 2022
GUILDFORD, UK / ACCESSWIRE / April 20, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its preliminary results for the year ended 31 December 2021 on...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Poster on Parsortix System Presented at AACR 2022
April 14, 2022
PARSORTIX SYSTEM RESULTS PUBLISHED AS A POSTER AT LEADING CANCER CONFERENCE AACR 2022 Poster demonstrated use of Parsortix workflow for triple negative breast cancer GUILDFORD, UK / ACCESSWIRE / April...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Identifying Drug Targets in Cancer Metastasis
April 01, 2022
PARSORTIX SYSTEM DEMONSTRATES ABILITY TO ISOLATE CTCs FOR DOWNSTREAM MOLECULAR ANALYSIS, IDENTIFYING KEY DRUG TARGETS INVOLVED IN CANCER METASTASIS - World-class research identifies specific genetic...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Rapid Information on Patient Response to Therapies
March 29, 2022
PARSORTIX SYSTEM SHOWS POTENTIAL FOR PROVIDING RAPID INFORMATION ON PATIENT RESPONSE TO THERAPIES TARGETING METASTASIS - Existing chemotherapies, such as vinorelbine, may selectively target and reduce...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Identifying Therapeutic Targets in TNBC Patients
March 25, 2022
PARSORTIX SHOWS POTENTIAL FOR IDENTIFYING THERAPEUTIC TARGETS IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER - Parsortix system harvests intact CTCs for whole genome sequencing identifying multiple...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Update on Laboratory Accreditation
March 15, 2022
ANGLE's US clinical laboratory issued Certificate of Registration, a key step to achieving CLIA accreditation GUILDFORD, UK / ACCESSWIRE / March 15, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a...
From
ANGLE plc
Via
AccessWire
Angle PLC Announces Holding(s) in Company
March 02, 2022
GUILDFORD, SURREY / ACCESSWIRE / March 2, 2022 / ANGLE plc (OTCQX:ANPCY )(AIM:AGL) TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0034330679 Issuer Name ANGLE plc UK or...
From
ANGLE plc
Via
AccessWire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
